Cargando…
Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959519/ https://www.ncbi.nlm.nih.gov/pubmed/17634114 http://dx.doi.org/10.1186/1472-6750-7-41 |
_version_ | 1782134632640151552 |
---|---|
author | Pluta, Krzysztof Diehl, William Zhang, Xian-Yang Kutner, Robert Bialkowska, Agnieszka Reiser, Jakob |
author_facet | Pluta, Krzysztof Diehl, William Zhang, Xian-Yang Kutner, Robert Bialkowska, Agnieszka Reiser, Jakob |
author_sort | Pluta, Krzysztof |
collection | PubMed |
description | BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA polymerase II (Pol II) or RNA polymerase III (Pol III) promoters, controlled by drug-responsive transactivators or repressors such as tetracycline (Tet)-dependent transactivators and repressors. However, the usefulness of these approaches is often times limited, caused by inefficient delivery and/or expression of shRNA-encoding sequences in target cells and/or poor design of shRNAs sequences. With a view toward optimizing Tet-regulated shRNA expression in mammalian cells, we compared the capacity of a variety of hybrid Pol III promoters to express short shRNAs in target cells following lentivirus-mediated delivery of shRNA-encoding cassettes. RESULTS: RNAi-mediated knockdown of gene expression in target cells, controlled by a modified Tet-repressor (TetR) in the presence of doxycycline (Dox) was robust. Expression of shRNAs from engineered human U6 (hU6) promoters containing a single tetracycline operator (TO) sequence between the proximal sequence element (PSE) and the TATA box, or an improved second-generation Tet-responsive promoter element (TRE) placed upstream of the promoter was tight and reversible as judged using quantitative protein measurements. We also established and tested a novel hU6 promoter system in which the distal sequence element (DSE) of the hU6 promoter was replaced with a second-generation TRE. In this system, positive regulation of shRNA production is mediated by novel Tet-dependent transactivators bearing transactivation domains derived from the human Sp1 transcription factor. CONCLUSION: Our modified lentiviral vector system resulted in tight and reversible knockdown of target gene expression in unsorted cell populations. Tightly regulated target gene knockdown was observed with vectors containing either a single TO sequence or a second-generation TRE using carefully controlled transduction conditions. We expect these vectors to ultimately find applications for tight and reversible RNAi in mammalian cells in vivo. |
format | Text |
id | pubmed-1959519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-19595192007-08-31 Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study Pluta, Krzysztof Diehl, William Zhang, Xian-Yang Kutner, Robert Bialkowska, Agnieszka Reiser, Jakob BMC Biotechnol Research Article BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA polymerase II (Pol II) or RNA polymerase III (Pol III) promoters, controlled by drug-responsive transactivators or repressors such as tetracycline (Tet)-dependent transactivators and repressors. However, the usefulness of these approaches is often times limited, caused by inefficient delivery and/or expression of shRNA-encoding sequences in target cells and/or poor design of shRNAs sequences. With a view toward optimizing Tet-regulated shRNA expression in mammalian cells, we compared the capacity of a variety of hybrid Pol III promoters to express short shRNAs in target cells following lentivirus-mediated delivery of shRNA-encoding cassettes. RESULTS: RNAi-mediated knockdown of gene expression in target cells, controlled by a modified Tet-repressor (TetR) in the presence of doxycycline (Dox) was robust. Expression of shRNAs from engineered human U6 (hU6) promoters containing a single tetracycline operator (TO) sequence between the proximal sequence element (PSE) and the TATA box, or an improved second-generation Tet-responsive promoter element (TRE) placed upstream of the promoter was tight and reversible as judged using quantitative protein measurements. We also established and tested a novel hU6 promoter system in which the distal sequence element (DSE) of the hU6 promoter was replaced with a second-generation TRE. In this system, positive regulation of shRNA production is mediated by novel Tet-dependent transactivators bearing transactivation domains derived from the human Sp1 transcription factor. CONCLUSION: Our modified lentiviral vector system resulted in tight and reversible knockdown of target gene expression in unsorted cell populations. Tightly regulated target gene knockdown was observed with vectors containing either a single TO sequence or a second-generation TRE using carefully controlled transduction conditions. We expect these vectors to ultimately find applications for tight and reversible RNAi in mammalian cells in vivo. BioMed Central 2007-07-16 /pmc/articles/PMC1959519/ /pubmed/17634114 http://dx.doi.org/10.1186/1472-6750-7-41 Text en Copyright © 2007 Pluta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Pluta, Krzysztof Diehl, William Zhang, Xian-Yang Kutner, Robert Bialkowska, Agnieszka Reiser, Jakob Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title | Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title_full | Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title_fullStr | Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title_full_unstemmed | Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title_short | Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
title_sort | lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959519/ https://www.ncbi.nlm.nih.gov/pubmed/17634114 http://dx.doi.org/10.1186/1472-6750-7-41 |
work_keys_str_mv | AT plutakrzysztof lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy AT diehlwilliam lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy AT zhangxianyang lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy AT kutnerrobert lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy AT bialkowskaagnieszka lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy AT reiserjakob lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy |